Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child

scientific article published on 01 January 1994

Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1651-2227.1994.TB12958.X
P698PubMed publication ID8193480

P2093author name stringW Muntean
W Zenz
G Zobel
A Beitzke
K Finding
P433issue1
P304page(s)84-87
P577publication date1994-01-01
P1433published inActa PaediatricaQ4676739
P1476titleInhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child
P478volume83

Reverse relations

cites work (P2860)
Q33546321Acquired factor V inhibitors
Q47301020Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin
Q37492672Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety
Q33603024Clinical and laboratory manifestations of anti-factor V antibodies
Q37586947Clinical use of topical thrombin as a surgical hemostat
Q34152394Evolution of hemostatic agents in surgical practice
Q45725988Postoperative Acquired Coagulopathy: A Pilot Study to Determine the Impact on Clinical and Economic Outcomes
Q73546192Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation
Q71787430Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression
Q77291988Risks of using platelet rich plasma gel
Q37979181Thrombin use in surgery: an evidence-based review of its clinical use.

Search more.